Home Cart 0 Sign in  

[ CAS No. 885693-20-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 885693-20-9
Chemical Structure| 885693-20-9
Structure of 885693-20-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 885693-20-9 ]

Related Doc. of [ 885693-20-9 ]

Alternatived Products of [ 885693-20-9 ]

Product Details of [ 885693-20-9 ]

CAS No. :885693-20-9 MDL No. :MFCD10697911
Formula : C16H28BNO4 Boiling Point : -
Linear Structure Formula :- InChI Key :KEEIJBAOTMNSEN-UHFFFAOYSA-N
M.W : 309.21 Pubchem ID :49835909
Synonyms :

Calculated chemistry of [ 885693-20-9 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.81
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 91.9
TPSA : 48.0 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.34
Log Po/w (WLOGP) : 2.8
Log Po/w (MLOGP) : 1.54
Log Po/w (SILICOS-IT) : 1.18
Consensus Log Po/w : 1.57

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.97
Solubility : 0.333 mg/ml ; 0.00108 mol/l
Class : Soluble
Log S (Ali) : -2.99
Solubility : 0.318 mg/ml ; 0.00103 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.448 mg/ml ; 0.00145 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 4.13

Safety of [ 885693-20-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 885693-20-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 885693-20-9 ]
  • Downstream synthetic route of [ 885693-20-9 ]

[ 885693-20-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 180691-65-0 ]
  • [ 73183-34-3 ]
  • [ 885693-20-9 ]
YieldReaction ConditionsOperation in experiment
71% With 1,1'-bis-(diphenylphosphino)ferrocene; potassium acetate In 1,4-dioxane at 80℃; for 16 h; PdCl2dppf (0.16 g, 0.22 mmol), KOAc (2.18 g, 22.2 mmol), 4,4,5,5,4',4',5',5'- octamethyl-[2,2']bi[[l,3,2]dioxaborolanyl] (2.07 g, 8.13 mmol), and dppf (0.12 g, 0.22 mmol) were placed in a round-bottomed flask, and the flask was flushed with Ar. A degassed solution of 5-trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-l-carboxylic acid tert-butyl ester (as prepared in the previous step, 2.45 g, 7.40 mmol) in dioxane (70 mL) was added to the flask and heated to 80 0C for 16 h. The mixture was filtered through a glass-fritted funnel to remove the solid KOAc, and the filtrate was concentrated in vacuo. Silica gel chromatography (5 percent EtOAc in hexanes) afforded the title compound (1.62 g, 71 percent) as a colorless oil. 1H-NMR (CDCl3; 400 MHz): δ 6.69-6.60 (m, IH), 3.98 (br s, 2H), 3.49-3.42 (m, 2H), 2.24-2.16 (m, 2H), 1.47 (s, 9H), 1.27 (s, 12H). LC-MS (ESI, m/z): Calcd. for Ci8H28BNO4 310.2 (M+H), found 311.0.
71% With potassium acetate In 1,4-dioxane at 80℃; for 16 h; PdCl2dppf (0.16 g, 0.22 mmol), KOAc (2.18 g, 22.2 mmol), 4,4,5,5,4',4',5',5'-octamethyl-[2,2']bi[[1,3,2]dioxaborolanyl] (2.07 g, 8.13 mmol), and dppf(0.12 g, 0.22 mmol) were placed in a round-bottomed flask, and the flask was flushed with Ar. A degassed solution of 5-trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester (as prepared in the previous step, 2.45 g, 7.40 mmol) in dioxane (70 mL) was added to the flask and heated to 80° C. for 16 h. The mixture was filtered through a glass-fritted funnel to remove the solid KOAc, and the filtrate was concentrated in vacuo. Silica gel chromatography (5percent EtOAc in hexanes) afforded the title compound (1.62 g, 71percent) as a colorless oil. 1H-NMR (CDCl3; 400 MHz): δ 6.69-6.60 (m, 1H), 3.98 (br s, 2H), 3.49-3.42 (m, 2H), 2.24-2.16 (m, 2H), 1.47 (s, 12H). LC-MS (ESI, m/z): Calcd. for C18H28BNO4 310.2 (M+H), found 311.0.
71% With potassium acetate In 1,4-dioxane at 80℃; for 16 h; b)
5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester
PdCl2dppf (0.16 g, 0.22 mmol), KOAc (2.18 g, 22.2 mmol), 4,4,5,5,4',4',5',5'-octamethyl-[2,2']bi[[1,3,2]dioxaborolanyl] (2.07 g, 8.13 mmol), and dppf (0.12 g, 0.22 mmol) were placed in a round-bottomed flask, and the flask was flushed with Ar.
A degassed solution of 5-trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester (as prepared in the previous step, 2.45 g, 7.40 mmol) in dioxane (70 mL) was added to the flask and heated to 80° C. for 16 h.
The mixture was filtered through a glass-fritted funnel to remove the solid KOAc, and the filtrate was concentrated in vacuo.
Silica gel chromatography (5percent EtOAc in hexanes) afforded the title compound (1.62 g, 71percent) as a colorless oil. 1H-NMR (CDCl3; 400 MHz): δ 6.69-6.60 (m, 1H), 3.98 (br s, 2H), 3.49-3.42 (m, 2H), 2.24-2.16 (m, 2H), 1.47 (s, 9H), 1.27 (s, 12H). LC-MS (ESI, m/z): Calcd. for C18H28BNO4 310.2 (M+H).
found 311.0.
71% With 1,1'-bis(diphenylphosphino)ferrocene; potassium acetate In 1,4-dioxane at 80℃; for 16 h; PdCl2dppf (0.16 g, 0.22 mmol), KOAc (2.18 g, 22.2 mmol), 4,4,5,5,4',4',5',5'- octamethyl-[2,2']bi[[l,3,2]dioxaborolanyl] (2.07 g, 8.13 mmol), and dppf (0.12 g, 0.22 mmol) were placed in a round-bottomed flask, and the flask was flushed with Ar. A degassed solution of 5-trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-l- carboxylic acid tert-butyl ester (as prepared in the previous step, 2.45 g, 7.40 mmol) in dioxane (70 mL) was added to the flask and heated to 80 0C for 16 h. The mixture was filtered through a glass-fritted funnel to remove the solid KOAc, and the filtrate was concentrated in vacuo. Silica gel chromatography (5 percent EtOAc in hexanes) afforded the title compound (1.62 g, 71 percent) as a colorless oil. 1H-NMR (CDCl3; 400 MHz): δ 6.69-6.60 (m, IH), 3.98 (br s, 2H), 3.49-3.42 (m, 2H), 2.24-2.16 (m, 2H), 1.47 (s, 9H), 1.27 (s, 12H). LC-MS (ESI, m/z): Calcd. for C18H28BNO4 310.2 (M+H), found 311.0.
70% With 1,1'-bis-(diphenylphosphino)ferrocene; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 80℃; for 18 h; Inert atmosphere Step 2
To a degassed solution of 5-trifluoromethanesulfonyloxy-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester (340 mg, 1.0 mmol, 1 eq) in dioxane (10 mL) was added bis-(pinacolato)-diboron (287 mg, 1.1 mmol, 1.1 eq), potassium acetate (302 mg, 3.0 mmol, 3 eq), 1,1'-bis(diphenylphosphino)ferrocene (17 mg, 0.03 mmol, 0.03 eq) and dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium) (23 mg, 0.03 mmol, 0.03 eq) were added.
The mixture was stirred at 80° C. for 18 h.
After cooling down, the mixture was filtered and the filtrate was concentrated and purified by flash chromatography using cyclohexane and ethyl acetate (100/0 to 96/4) to afford the corresponding boronic ester (225 mg, 70percent yield).
64% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 80℃; Inert atmosphere To a solution of tert-butyl 3-(trifluoromethylsulfonyloxy)-5,6-dihydropyridine- l(2H)- carboxylate (503-2) (1.4 g, 4.3 mmol), BPin ( 1.3 g, 5.1 mmol) and KOAc (1.26 g, 12.9 mmol) in dioxane (10 mL) was added Pd(dppf)Cl2.DCM (351 mg, 0.43 mmol). The resulting mixture was purged with N2 X 3 and heated to 80 °C overnight. The solvent was removed in vacuo and the residue was purified by column chromatography (silica gel, 0 to 10percent EA in PE) to give tert-butyl 3-(4,4,5,5-tetramethyl- 1,3,2- dioxaborolan-2-yl)-5,6-dihydropyridine-l(2H)-carboxylate (503-3) (850 mg, 64percent) as a yellow oil.
42% With potassium acetate In 1,4-dioxane at 80℃; for 12 h; To a high pressure vessel was added 5-trifluoromethanesulfonyloxy-3,6- dihydro-2H-pyridine- l-carboxylic acid tert-butyl ester (1.0 g, 3.0 mmol), dichloro[l ,l '- bis(diphenylphosphino)ferrocene]palladium (II) acetone adduct (0.2 g, 0.3 mmol), Ι , - bis(diphenylphosphino)ferrocene (0.2 g, 0.3 mmol), bis(pinacolato)diboron (0.84 g, 3.3 mmol) and K2OAc (0.89 g, 9.0 mmol) in 1 ,4-dioxane (7 mL, 90 mmol). The reaction was heated for 12 h at 80 °C. After cooling to RT, the mixture was diluted with EtOAc, the organic phase was concentrated in vacuo, and the residue purified by column chromatography to afford the named compound (42percent). .H NMR (CDC13, 400 MHz): δ 6.57 (br. s., 1H), 3.91 (br. s., 2H), 3.39 (t, J = 5.81 Hz, 2H), 2.13 (br. s., 2H), 1.39-1.41 (m, 9H), 1.19 (s, 12H).
41% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl-formamide at 85℃; for 4 h; Inert atmosphere A mixture of tert-butyl 5-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate (3.5 g, 14.5 mmol), Pd(dppf)Cl2 (0.38 g, 0.53 mmol), bis(pinacolato)diboron (3.9 g, 15.8 mmol), and KOAc (3.1 g, 31.5 mmol) in anhydrous DMF was degassed and purged with nitrogen three times.
The mixture was heated at 85° C. for 4 h.
After cooling down to room temperature, the reaction was diluted with ethyl acetate, filtered, and concentrated.
The crude residue was purified by silica gel column chromatography to afford tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate (1.4 g, 41percent) as a colorless oil.

Reference: [1] Patent: WO2006/47277, 2006, A2, . Location in patent: Page/Page column 97
[2] Patent: US2006/281788, 2006, A1, . Location in patent: Page/Page column 73
[3] Patent: US2008/51402, 2008, A1, . Location in patent: Page/Page column 60
[4] Patent: WO2007/48088, 2007, A2, . Location in patent: Page/Page column 115
[5] Patent: US2013/102601, 2013, A1, . Location in patent: Paragraph 184
[6] Patent: WO2016/4272, 2016, A1, . Location in patent: Paragraph 00654
[7] Patent: WO2011/29046, 2011, A1, . Location in patent: Page/Page column 122; 123
[8] Patent: US2018/72743, 2018, A1, . Location in patent: Paragraph 1625-1626
[9] Patent: US2007/105864, 2007, A1, . Location in patent: Page/Page column 180
[10] Patent: WO2012/127506, 2012, A1, . Location in patent: Page/Page column 68-69
[11] Patent: WO2010/59771, 2010, A1, . Location in patent: Page/Page column 47
  • 2
  • [ 98977-36-7 ]
  • [ 885693-20-9 ]
  • [ 1121057-77-9 ]
Reference: [1] Patent: WO2011/143495, 2011, A1, . Location in patent: Page/Page column 85
  • 3
  • [ 98977-36-7 ]
  • [ 885693-20-9 ]
Reference: [1] Patent: WO2011/29046, 2011, A1,
[2] Patent: WO2012/127506, 2012, A1,
[3] Patent: WO2016/4272, 2016, A1,
[4] Patent: US2017/174641, 2017, A1,
[5] Patent: US2018/72743, 2018, A1,
[6] Patent: US2013/102601, 2013, A1,
[7] Patent: WO2010/59771, 2010, A1,
  • 4
  • [ 180691-65-0 ]
  • [ 885693-20-9 ]
Reference: [1] Patent: US2017/174641, 2017, A1,
  • 5
  • [ 86447-11-2 ]
  • [ 885693-20-9 ]
Reference: [1] Patent: CN105503924, 2016, A,
  • 6
  • [ 98977-36-7 ]
  • [ 885693-20-9 ]
  • [ 1121057-77-9 ]
Reference: [1] Patent: WO2011/143495, 2011, A1, . Location in patent: Page/Page column 85
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 885693-20-9 ]

Organoboron

Chemical Structure| 212127-83-8

[ 212127-83-8 ]

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate

Similarity: 0.92

Chemical Structure| 286961-14-6

[ 286961-14-6 ]

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.91

Chemical Structure| 905273-91-8

[ 905273-91-8 ]

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate

Similarity: 0.85

Chemical Structure| 900503-08-4

[ 900503-08-4 ]

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

Similarity: 0.84

Chemical Structure| 286961-15-7

[ 286961-15-7 ]

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.81

Amides

Chemical Structure| 212127-83-8

[ 212127-83-8 ]

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate

Similarity: 0.92

Chemical Structure| 286961-14-6

[ 286961-14-6 ]

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.91

Chemical Structure| 905273-91-8

[ 905273-91-8 ]

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate

Similarity: 0.85

Chemical Structure| 900503-08-4

[ 900503-08-4 ]

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate

Similarity: 0.84

Chemical Structure| 286961-15-7

[ 286961-15-7 ]

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.81

Related Parent Nucleus of
[ 885693-20-9 ]

Pyridines

Chemical Structure| 286961-14-6

[ 286961-14-6 ]

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.91

Chemical Structure| 286961-15-7

[ 286961-15-7 ]

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate

Similarity: 0.81

Chemical Structure| 1121057-77-9

[ 1121057-77-9 ]

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate

Similarity: 0.75

Chemical Structure| 1227068-67-8

[ 1227068-67-8 ]

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone

Similarity: 0.73

Chemical Structure| 844501-00-4

[ 844501-00-4 ]

(1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid

Similarity: 0.72